Transcranial Alternating Current Stimulation for Treatment-Resistant Depression

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
Treatment-Resistant Depression
Interventions
DEVICE

transcranial alternating current stimulation (tACS)

"Three conductive electrodes will be applied to the scalp: one 4.45 × 9.53 cm electrode placed over the forehead (Fpz, Fp1, and Fp2 in the 10/20 international placement system) and two 3.18 × 3.81 cm electrodes over the mastoid areas.~The tACS stimulation waveform includes ramp-up and ramp-down periods of 180 and 12 s, respectively. It is a square-wave with an average amplitude of 15 mA and is equally distributed from the frontal region to the mastoid areas (amplitudes are reported as zero-to-peak).~Each subject will receive 40 sessions of tACS intervention during 4 consecutive weeks at a fixed day time twice per day (once in morning and afternoon, respectively) from Monday through Friday. Each session lasts 40 min."

DEVICE

Sham tACS

Sham tACS

All Listed Sponsors
collaborator

Ningcheng Center Hospital

UNKNOWN

collaborator

Changning Mental Health Center

UNKNOWN

collaborator

Tianjin Anding Hospital

OTHER

collaborator

Kangning Hospital, Ningbo University

UNKNOWN

lead

Xuanwu Hospital, Beijing

OTHER

NCT06172413 - Transcranial Alternating Current Stimulation for Treatment-Resistant Depression | Biotech Hunter | Biotech Hunter